Stock listing
NASDAQ:IMMX Immix Biopharma, Inc. Stock
Home listing (NASDAQ) of Immix Biopharma, Inc.
Follow Immix Biopharma, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:IMMX
$7.11 USD -0.09 (-1.2%)
Close on Nov 18, 2026
- Day range
- $7.05 – $7.43 USDNov 18, 2026
- Volume
- 876,255 sharesNov 18, 2026
- Market cap
- $589.4M USDAt the close on Nov 18, 2026 · price × 82.90M shares outstanding
- 52-week range
- $3.78 – $15.10 USDLowest and highest trades, Nov 19, 2025 – Nov 18, 2026
- Traded on an average day
- $15.67M USDMedian day 1.30M shares · last 3 months, Aug 18, 2026 – Nov 18, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:IMMX · Home | $7.11 USD | -0.09 (-1.2%) | 876,255 | $7.235 | $7.43 | $7.05 | $7.20 | Close on Nov 18, 2026 |
Daily closes
Last 3 months, Aug 18, 2026 – Nov 18, 2026 · NASDAQ:IMMX · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $7.11 | -0.09 | -1.2% | $7.235 | $7.43 | $7.05 | 876,255 | |
| $7.20 | -0.28 | -3.7% | $7.48 | $7.52 | $7.12 | 993,758 | |
| $7.48 | -0.36 | -4.6% | $7.83 | $8.01 | $7.455 | 1,004,634 | |
| $7.84 | -0.23 | -2.9% | $8.25 | $8.375 | $7.66 | 1,027,813 | |
| $8.07 | -0.59 | -6.8% | $8.40 | $8.45 | $8.06 | 954,606 | |
| $8.66 | +0.31 | +3.7% | $8.40 | $8.72 | $8.30 | 1,070,704 | |
| $8.35 | -0.22 | -2.6% | $8.37 | $8.77 | $8.132 | 825,479 | |
| $8.57 | +0.51 | +6.3% | $8.09 | $8.89 | $7.90 | 1,270,839 | |
| $8.06 | +0.86 | +11.9% | $7.24 | $8.17 | $7.18 | 1,444,882 | |
| $7.20 | -0.77 | -9.7% | $7.86 | $7.95 | $7.12 | 1,414,576 | |
| $7.97 | +0.26 | +3.4% | $7.93 | $8.16 | $7.56 | 1,249,715 | |
| $7.71 | +0.45 | +6.2% | $7.33 | $7.80 | $7.168 | 1,072,329 | |
| $7.26 | -0.42 | -5.5% | $7.65 | $7.913 | $7.185 | 1,506,997 | |
| $7.68 | -0.30 | -3.8% | $7.86 | $8.10 | $7.56 | 1,381,203 | |
| $7.98 | -0.145 | -1.8% | $8.11 | $8.36 | $7.835 | 1,073,785 | |
| $8.125 | +0.075 | +0.9% | $7.98 | $8.21 | $7.88 | 1,229,694 | |
| $8.05 | -0.01 | -0.1% | $8.00 | $8.16 | $7.849 | 1,147,026 | |
| $8.06 | -0.09 | -1.1% | $8.17 | $8.31 | $7.99 | 1,116,278 | |
| $8.15 | -0.20 | -2.4% | $8.34 | $8.89 | $7.88 | 1,203,479 | |
| $8.35 | -0.16 | -1.9% | $8.40 | $8.73 | $8.23 | 817,970 | |
| $8.51 | -0.40 | -4.5% | $8.94 | $9.10 | $8.47 | 1,540,507 | |
| $8.91 | +0.69 | +8.4% | $8.26 | $9.03 | $8.235 | 1,226,147 | |
| $8.22 | +0.24 | +3.0% | $8.05 | $8.35 | $8.00 | 1,302,419 | |
| $7.98 | -0.70 | -8.1% | $8.67 | $8.67 | $7.95 | 1,503,800 | |
| $8.68 | +0.17 | +2.0% | $8.51 | $8.905 | $8.45 | 1,314,400 | |
| $8.51 | -0.18 | -2.1% | $8.60 | $8.87 | $8.42 | 1,360,500 | |
| $8.69 | -0.56 | -6.1% | $9.10 | $9.29 | $8.66 | 1,483,600 | |
| $9.25 | -0.21 | -2.2% | $9.42 | $9.56 | $9.18 | 936,200 | |
| $9.46 | +0.17 | +1.8% | $9.29 | $9.53 | $9.18 | 1,109,000 | |
| $9.29 | -0.20 | -2.1% | $9.34 | $9.37 | $8.96 | 1,289,000 | |
| $9.49 | -0.15 | -1.6% | $9.50 | $9.69 | $9.40 | 1,382,100 | |
| $9.64 | -0.49 | -4.8% | $10.20 | $10.20 | $9.515 | 1,214,600 | |
| $10.13 | +0.45 | +4.6% | $9.71 | $10.33 | $9.55 | 1,597,500 | |
| $9.68 | -0.55 | -5.4% | $10.35 | $10.37 | $9.48 | 2,548,000 | |
| $10.23 | -0.175 | -1.7% | $10.25 | $10.48 | $9.86 | 1,648,300 | |
| $10.41 | -0.135 | -1.3% | $10.61 | $11.25 | $10.39 | 2,408,600 | |
| $10.54 | -0.93 | -8.1% | $11.64 | $11.85 | $10.07 | 5,759,500 | |
| $11.47 | +0.50 | +4.6% | $10.82 | $11.84 | $10.70 | 995,600 | |
| $10.97 | -0.73 | -6.2% | $11.78 | $11.99 | $10.82 | 1,828,200 | |
| $11.70 | -0.22 | -1.8% | $11.87 | $11.97 | $11.19 | 1,535,800 | |
| $11.92 | -0.91 | -7.1% | $12.80 | $12.84 | $11.71 | 1,168,200 | |
| $12.83 | +0.36 | +2.9% | $12.45 | $12.90 | $12.31 | 948,100 | |
| $12.47 | -0.03 | -0.2% | $12.59 | $12.71 | $12.14 | 1,329,500 | |
| $12.50 | -0.22 | -1.7% | $12.68 | $12.84 | $12.34 | 4,183,900 | |
| $12.72 | +0.80 | +6.7% | $12.24 | $12.75 | $12.07 | 1,184,700 | |
| $11.92 | -0.22 | -1.8% | $12.28 | $12.46 | $11.75 | 1,421,900 | |
| $12.14 | -0.07 | -0.6% | $12.49 | $12.63 | $11.81 | 1,054,900 | |
| $12.21 | +0.07 | +0.6% | $12.44 | $12.59 | $11.98 | 1,079,600 | |
| $12.14 | -0.56 | -4.4% | $12.86 | $13.29 | $12.02 | 1,190,300 | |
| $12.70 | +0.39 | +3.2% | $12.08 | $12.77 | $11.91 | 1,656,300 | |
| $12.31 | -0.94 | -7.1% | $13.12 | $13.23 | $12.24 | 1,285,600 | |
| $13.25 | -0.66 | -4.7% | $13.70 | $13.89 | $12.75 | 1,420,200 | |
| $13.91 | +0.08 | +0.6% | $13.68 | $14.09 | $13.60 | 1,050,700 | |
| $13.83 | -0.13 | -0.9% | $14.14 | $14.14 | $13.52 | 987,200 | |
| $13.96 | -0.05 | -0.4% | $14.00 | $14.23 | $13.42 | 1,578,200 | |
| $14.01 | -0.02 | -0.1% | $13.86 | $14.26 | $13.62 | 1,277,400 | |
| $14.03 | +0.09 | +0.6% | $13.70 | $14.15 | $13.52 | 1,326,800 | |
| $13.94 | -0.37 | -2.6% | $14.06 | $14.17 | $13.76 | 1,143,400 | |
| $14.31 | +0.24 | +1.7% | $14.03 | $14.61 | $13.77 | 1,511,000 | |
| $14.07 | -0.40 | -2.8% | $14.45 | $14.55 | $13.80 | 1,385,000 | |
| $14.47 | +0.86 | +6.3% | $13.60 | $15.10 | $13.49 | 3,651,500 | |
| $13.61 | -0.05 | -0.4% | $13.66 | $13.80 | $12.90 | 1,415,400 | |
| $13.66 | +0.50 | +3.8% | $13.36 | $13.76 | $13.12 | 1,510,600 | |
| $13.16 | -0.03 | -0.2% | $12.98 | $13.20 | $12.69 | 1,666,200 | |
| $13.19 | +1.38 | +11.7% | $11.99 | $13.19 | $11.99 | 1,975,400 | |
| $11.81 | +0.47 | +4.1% | $11.12 | $11.86 | $11.06 | 1,352,600 |
- Ticker
- NASDAQ:IMMX
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Nov 12, 2026
Immix Biopharma Reports Third Quarter 2026 Financial Results and Update on Corporate Progress
Latest deck · September 2026
Investor Presentation (September 2026)
Investor deck · 34 slides
Latest news
Immix Biopharma Reports Third Quarter 2026 Financial Results and Update on Corporate Progress
Nov 12, 2026
Closed $7.84 (-2.9%) on Nov 13, 2026
Immix Biopharma’s NXC-201 NEXICART-2 Interim Clinical Trial Results Selected for Oral Presentation at ASH 2026
Nov 4, 2026
Closed $7.97 (+3.4%) on Nov 4, 2026
Immix Biopharma to Participate in the 45th Annual J.P. Morgan Healthcare Conference
Oct 5, 2026
Closed $10.13 (+4.6%) on Oct 5, 2026
Immix Biopharma Announces Closing of $125 Million Underwritten Offering of Common Stock
Sep 30, 2026
Closed $10.23 (-1.7%) on Oct 1, 2026
Immix Biopharma Announces Pricing of $125 Million Underwritten Offering of Common Stock
Sep 29, 2026
Closed $10.54 (-8.1%) on Sep 29, 2026
Immix Biopharma Announces 89% Complete Response Rate at Interim Update Across All NEXICART-2 Patients, with MRD-Negativity Indicating Potential to Reach up to 98% Complete Response Rate, Supporting Potential Best-in-Class Therapy for Relapsed/Refracto...
Sep 29, 2026
Closed $10.54 (-8.1%) on Sep 29, 2026
Immix Biopharma to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference
Aug 4, 2026
Closed $9.33 (+10.8%) on Aug 4, 2026
Immix Biopharma Announces Closing of $150 Million Underwritten Offering of Common Stock
May 22, 2026
Closed $8.84 (+0.7%) on May 26, 2026
Immix Biopharma Announces Pricing of $150 Million Underwritten Offering of Common Stock
May 21, 2026
Closed $8.67 (-3.0%) on May 21, 2026
Financings
Public offering of common stock
Sep 29, 2026
Announced: US$125M · US$11 a share · J.P. Morgan
Dealers: J.P. Morgan (lead)
Buyers: Eventide Asset Management; Janus Henderson Investors; Ridgeback Capital Investments L.P.; Wellington Management
Use of proceeds: Fund NXC-201 development, working capital and general corporate purposes
Public offering of common stock and pre-funded warrants
Dec 7, 2025
Announced: US$100M · US$5.1 a share · Morgan Stanley +2
Dealers: Morgan Stanley (lead), Citizens Capital Markets, Mizuho
Use of proceeds: Fund NXC-201 development, working capital and general corporate purposes
Strategic investment of strategic investment
Sep 8, 2025
Closed: strategic investment
Buyers: Goose Capital; Dr. Nancy T. Chang
Decks
Investor Presentation (September 2026)
Investor deck · 34 slides · September 2026
Investor Presentation (August 2026)
Investor deck · 31 slides · August 2026
Investor Presentation (May 2026)
Investor deck · 50 slides · May 2026
Investor Presentation (March 2026)
Investor deck · 48 slides · March 2026
Immix Biopharma, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 19 in the last 12 months · 106 in all · newest Nov 12, 2026 · oldest 2021
- Decks
- 25 decks · latest September 2026
Where Immix Biopharma, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:IMMX · Home listing · This page | NASDAQ | United States | USD |
| BOATS:IMMX | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about Immix Biopharma, Inc.